All Posts by Dr. Spira

Return to Main

New Treatment Breakthrough: Amivantamab Plus Lazertinib for Advanced Lung Cancer - Timothy A. McCarthy, MD

Lung Cancer Team, Alex Spira, Clinical Trials and Research, Lung Cancer, Timothy A. McCarthy
July 22, 2024
Read More

Investigational Inhibitor of Active RAS Shows Clinical Promise - Alexander I. Spira, MD, PhD, FACP

Clinical Trials Search, Alex Spira, Clinical Trials and Research
October 16, 2023
Read More

Landmark Non-Small Cell Lung Cancer Study - Clinically Meaningful Improvement and Progression Free Survival, Alexander I. Spira, MD, PhD, FACP 

Lung Cancer Team, The Research Institute, Alex Spira, Clinical Trials and Research, Lung Cancer, Non-Small Cell Lung Cancer
September 28, 2023
Read More

A Rare Breakthrough in the Treatment of Colorectal Cancer Patients Harboring a KRAS mutation.

Alex Spira, Colon & Rectal Cancer, Clinical Trials and Research
March 7, 2023
Read More

NEXT-Virginia Opens Phase I Clinical Research Clinic for Oncology Patients in collaboration with Virginia Cancer Specialists

NEXT Oncology, The Research Institute, Alex Spira, Clinical Trials and Research, Press Releases
January 10, 2023
Read More

Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C - Co-Author Alexandar Spira, MD, PhD, FACP

Alex Spira, Colon & Rectal Cancer
January 9, 2023
Read More

Advancements in Lung Cancer Treatment Provide Hope for Virginia Cancer Specialists Patients - Alexander I. Spira, MD, PhD, FACP

Lung Cancer Team, Alex Spira, Lung Cancer
November 10, 2022
Read More

Shine A Light on Lung Cancer 2022

Thoracic Surgery, Events, Alex Spira, Lung Cancer, Gregory S. Sibley, Non-Small Cell Lung Cancer, Small Cell Lung Cancer
October 13, 2022
Read More

Ground breaking research leading to breakthroughs in cancer treatments - Timothy A. McCarthy, MD

ASCO, Lung Cancer Team, Alex Spira, Lung Cancer, Small Cell Lung Cancer, Timothy A. McCarthy
July 11, 2022
Read More

Virginia Cancer Patient “Living with (Stage 4) Cancer” Thanks to Clinical Trial

NEXT Oncology, The Research Institute, Alex Spira, Non-Small Cell Lung Cancer
June 27, 2022
Read More

Key Advances and Insights at the 2022 American Society of Clinical Oncology Annual Meeting - Alexander I. Spira, MD, PhD, FACP

Fairfax Office, Alex Spira
June 3, 2022
Read More

RESECTABLE NSCLC AND THE IMPORTANCE OF GUIDELINE-RECOMMENDED MOLECULAR TESTING

Thoracic Surgery, Fairfax Cancer Center, Fairfax Office, Lung Cancer Team, Alex Spira, Lung Cancer
February 22, 2022
Read More

Journal of Clinical Oncology - ASCO Pub - Abstract - Pancreatic Cancer and other GI Tumors harboring a KRAS (G12C) Mutation. Alex Spira, MD, PhD, FACP

Alex Spira, GI Cancer
January 20, 2022
Read More

Virginia Cancer Specialists Participating in National Pilot Project to Increase Diversity in Cancer Treatment Trials

The Research Institute, Alex Spira, Clinical Trials and Research, Mitul Gandhi
October 11, 2021
Read More

Next Oncology Expands Phase I Program with Virginia Cancer Specialists Partnership

NEXT Oncology, Alex Spira, Clinical Trials and Research
October 6, 2021
Read More

A monumental step forward in the treatment of non-small cell lung cancer patients harboring a KRAS mutation, Dr. Christina Brzezniak

Lung Cancer Team, Christina Brzezniak, Alex Spira, Lung Cancer, Non-Small Cell Lung Cancer
June 16, 2021
Read More

Alexander I Spira, MD, PhD, FACP - Sotorasib for Lung Cancers with KRAS p.G12C Mutation, The New England Journal of Medicine

Alex Spira, Lung Cancer
June 4, 2021
Read More

Exploring Why Testing in Lung Cancer is Important to Treatment Decisions - Alex Spira, MD, PhD, FACP

Alex Spira, Lung Cancer
February 23, 2021
Read More

Virginia Cancer Specialists Joins MYLUNG Consortium, Aiming to Advance Use of Precision Medicine for Metastatic Non-Small Cell Lung Cancer Patients

The Research Institute, Alex Spira, Clinical Trials and Research, Lung Cancer
February 4, 2021
Read More

Interview with Dr. Alex Spira - Medpage Today Lung Cancer and Covid19

Alex Spira, Lung Cancer
June 16, 2020
Read More

Alex Spira, MD PhD FACP VCS Co-Author Virginia Cancer Specialists - JAMA Network - Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas Clinical Trial

Alex Spira, Clinical Trials and Research, The Sarcoma Center, Sarcoma
April 9, 2020
Read More

Alexander Spira, MD, PhD, FACP, on the recent approval of atezolizumab in SCLC

Alex Spira, Lung Cancer
April 2, 2019
Read More

Virginia Cancer Specialists (VCS) Now Offering a Newly FDA-Approved Targeted Therapy for Acute Leukemia

Alex Spira, Clinical Trials and Research, Leukemia, Hematology and Blood Cancers, Dipti Patel-Donnelly
February 4, 2019
Read More

Advancements in Science and Cancer Care Research Announced at the US Oncology Research 17th Annual Science Forum - Dr. Alex Spira

The Research Institute, Alex Spira
October 8, 2018
Read More

Co Author Alex Spira, MD - Lung Cancer Study Treatment Option for ALK Positive Lung Cancer Patients

Alex Spira, Lung Cancer
September 25, 2018
Read More

Alex Spira, M.D., PhD, F.A.C.P. receives award for his work in Lung Cancer

Alex Spira, Lung Cancer
September 20, 2018
Read More

Virginia Cancer Specialists Collaborating with Caris Life Sciences to Present New Molecular Findings at the 2018 ASCO Annual Meeting

The Research Institute, Alex Spira, Amy J. Irwin MD
May 22, 2018
Read More

Dr. Alex Spira quoted in announcement from Mirati Theraputics: Progress Of Lead Programs And Updated Positive Clinical Trial Results For Immuno-Oncology Combination Trials

Alex Spira, Immunotherapy, Clinical Trials and Research
April 26, 2018
Read More

Virginia Cancer Specialists first patient successfully completes Cycle 1 of Treatment with PCM-075 combination with Low Dose Cytarabine (LDAC) AML Trial

The Research Institute, Alex Spira, Clinical Trials and Research, Leukemia
March 6, 2018
Read More

Alex Spira, MD Co-Author of collaborative study on Immunotherapy guidelines to guide clinicians and patients

Alex Spira, Immunotherapy
February 15, 2018
Read More

Virginia Cancer Specialists enrolls fist patient in Phase 1b/2 Clinical Trial of PCM-075 for Acute Myeloid Leukemia (AML)

Clinical Trials Search, The Research Institute, Alex Spira, Clinical Trials and Research, Leukemia
February 7, 2018
Read More

Northern Virginia 2018 Thoracic Oncology Symposium, CME Program - March 10th 2018

Alex Spira, CME Event, Timothy A. McCarthy
January 30, 2018
Read More

Award Winning Physicians

Our Physicians work for you, ensuring the highest standard of care.

Learn More
Return to Top